DEPRESSION:  BRINTELLIX

Dennis B. Kottler, MD

Westlake Village, CA

Appointments:   818-991-8376 

Email:   doc@psychiatrix.com

Return to Homepage


BRINTELLIX (vortioxetine) is a novel medication for the treatment of Depression.  It combines the advantages of an SSRI (selective serotonin reuptake inhibitor) with an agonist effect on serotonin (5-HT1A) receptors.  This dual mode of action is designed to enhance its effectiveness in treating depression.  This mode of action is similar to that of Viibryd.    

 

Some key advantages of BRINTELLIX include:

1 -  Novel dual mode of action as described above. 

2 -  Often effective in refractory patients (cases where other antidepressants have failed to work).

3 -  Flexible dosing available (5 mg - 10 mg - 15 mg  - 20 mg tablets) to accommodate individual patient needs.

4-   Well tolerated in most patients.

 

As with all medications there are potential side effects and other medical considerations to be evaluated prior to and during medication treatment.  It is essential to consult with a psychiatrist, or other physician, knowledgeable about Depression and related medical and psychiatric conditions.

Brintellix is manufactured by Takeda Pharmaceuticals. 


Return to Top

Return to Homepage


Appointments:   818-991-8376 

Email:   doc@psychiatrix.com